NK
NKGen Biotech, Inc. Warrants
NKGNW · NASDAQ
$0.03 +2,408.33% (+$0.03)
Market Cap $6.18M
P/E Ratio -
Div. Yield -
ROE 103.10%
Piotroski F-Score Moderate
4/9Valuation
0 /100
Expensive P/S 9.48x
P/E N/A
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
0 /100
Weak Gross margin 0.00%
Net margin 6,792.33%
Op. margin 4,135.89%
Quality
75 /100
Excellent ROE 103.10%
ROA 184,525.00%
Asset turnover 27.17x
Debt
64 /100
Moderate Int. coverage 0.00x
Net debt/EBITDA 0.00x
Debt/Equity N/A
Stability
37 /100
Moderate Beta 0.64x
EPS volatility 211.35%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about NKGNW
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Paul Y. Song
Employees
63
Headquarters
Santa Ana